Brightflow closed $18.2M Series A round

Brightflow SAS has successfully completed an oversubscribed Series A financing round, securing €16.5 million (approximately $18 million). The round was led by new investors VIVES Partners, Majycc Innovation Santé - UI Investissement, and BNP Paribas Development, along with international business angels. Existing investors GO Capital and Karista also participated in this funding round.

The Paris-based medical device company is developing a fully percutaneous long-term right ventricular (RV) mechanical circulatory support system. This technology is designed to treat end-stage heart failure in patients suffering from severe RV dysfunction, without requiring open-heart surgery. The funds will be used to advance the company's strategic initiatives through early 2026, which include completing product development and beginning the first compassionate implantations of their device.